FAS and neoplasm: Tumors in Lynch Syndrome patients do not appear to invoke other immune subversion processes such as Fas counterattack of the infiltrating lymphocytes, as evidenced by work correlating FasL expression with tumor cell apoptosis and the number of TILs [148].